Live from the NIH registry
Studies recruiting near Rochester right now
Top 25 of 471 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Rochester — Rochester, New York (0.9 mi)
· Sponsor: SWOG Cancer Research Network
A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
Follicular Lymphoma, Marginal Zone Lymphoma
Phase 1, Phase 2
Interventional 80 participants sought
University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center) — Rochester, New York (0.9 mi)
· Sponsor: Enterome
A Study of ASP3082 in Adults With Advanced Solid Tumors
Solid Tumor
Phase 1
Interventional 681 participants sought
University of Rochester Medical Center James P. Wilmot Cancer Center — Rochester, New York (0.9 mi)
· Sponsor: Astellas Pharma Inc
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Phase 1, Phase 2
Interventional 270 participants sought
Xencor Investigative Site — Rochester, New York (0.9 mi)
· Sponsor: Xencor, Inc.
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
University of Rochester — Rochester, New York (0.9 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
University of Rochester Medical Center - PPDS — Rochester, New York (0.9 mi)
· Sponsor: Takeda
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
University of Rochester — Rochester, New York (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Multiple Myeloma
Phase 2
Interventional 210 participants sought
University of Rochester Medical Center — Rochester, New York (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Wilmot Cancer Institute — Rochester, New York (0.9 mi)
· Sponsor: Eli Lilly and Company
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Glioblastoma, GBM
Phase 2
Interventional 103 participants sought
University of Rochester — Rochester, New York (0.9 mi)
· Sponsor: Alpheus Medical, Inc.
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
University of Rochester — Rochester, New York (0.9 mi)
· Sponsor: SWOG Cancer Research Network
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 316 participants sought
University of Rochester - Cardiology CCTU — Rochester, New York (0.9 mi)
· Sponsor: Orchestra BioMed, Inc
Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
Basal Cell Carcinoma
N/A
Interventional 52 participants sought
Rochester Dermatologic Surgery — Victor, New York (16.5 mi)
· Sponsor: University of Rochester
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
University of Rochester Medical Center — Rochester, New York (0.9 mi)
· Sponsor: Pfizer
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
Heart Failure With Preserved Ejection Fraction (HFpEF
N/A
Interventional 150 participants sought
Rochester General Hospital — Rochester, New York (0.9 mi)
· Sponsor: Axon Therapies, Inc.
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
University of Rochester — Rochester, New York (0.9 mi)
· Sponsor: SWOG Cancer Research Network
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
Phase 2
Interventional 48 participants sought
31787, University of Rochester Adult HIV Therapeutic Strategies Network CRS — Rochester, New York (0.9 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
Basal Cell Carcinoma
Phase 2
Interventional 80 participants sought
Research Site — Rochester, New York (0.9 mi)
· Sponsor: Stamford Pharmaceuticals, Inc.
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Systemic Lupus Erythematosus, Active Refractory Rheumatoid Arthritis
Phase 2
Interventional 220 participants sought
University of Rochester Medical Center — Rochester, New York (0.9 mi)
· Sponsor: Amgen
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
Single Gene NIPT
N/A
Observational 4,000 participants sought
University of Rochester — Rochester, New York (0.9 mi)
· Sponsor: Natera, Inc.
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — Rochester, New York (0.9 mi)
· Sponsor: AstraZeneca
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
Rochester General Hospital — Rochester, New York (0.9 mi)
· Sponsor: Edwards Lifesciences
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Rochester, New York (0.9 mi)
· Sponsor: AstraZeneca
Visual Perception in Schizophrenia
Schizophrenia Disorders, Bipolar Disorder
N/A
Interventional 84 participants sought
University of Rochester — Rochester, New York (0.9 mi)
· Sponsor: University of Rochester
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Rochester Clinical Research, Inc — Rochester, New York (0.9 mi)
· Sponsor: Boehringer Ingelheim